reports
Tekla Life Sciences Investors Paid Distribution
BOSTON--(BUSINESS WIRE)-- On March 29, 2018, Tekla Life Sciences Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sa...
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Pro...
BOSTON--(BUSINESS WIRE)-- Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2018. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year-period ending July 14, 2019. The Board authorized the share repurchase program as ...
Tekla Life Sciences Investors Declares Stock Distribution
BOSTON--(BUSINESS WIRE)-- On February 16, 2018, Tekla Life Sciences Investors declared a stock distribution of $0.40 per share. The record date for the stock distribution is February 28, 2018 and the payable date is March 29, 2018. The Fund will trade ex-distribution on February 27, 2018. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23...
A director bought 1,300 shares at 21.037USD and
A director at Tekla Life Sciences Investors bought 1,300 shares at 21.037USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Tekla Life Sciences Investors Paid Distribution
BOSTON, Mass.--(BUSINESS WIRE)-- On December 29, 2017, Tekla Life Sciences Investors paid a distribution of $0.43 per share. It is currently estimated that this distribution is derived from net realized short-term gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses o...
Tekla Life Sciences Investors Declares Stock Distribution
BOSTON--(BUSINESS WIRE)-- On November 17, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.43 per share. The record date for the stock distribution is November 28, 2017 and the payable date is December 29, 2017. The Fund will trade ex-distribution on November 27, 2017. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, Decem...
Tekla Life Sciences Investors Paid Distribution
BOSTON--(BUSINESS WIRE)-- On September 29, 2017, Tekla Life Sciences Investors paid a distribution of $0.42 per share. It is currently estimated that this distribution is derived from short-term and long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $180,845,130, of wh...
Tekla Life Sciences Investors Declares Stock Distribution
BOSTON--(BUSINESS WIRE)-- On August 18, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.42 per share. The record date for the stock distribution is August 28, 2017 and the payable date is September 29, 2017. The Fund will trade ex-distribution on August 24, 2017. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, September ...
Tekla Life Sciences Investors Announces Results of Annual Shareholders...
BOSTON--(BUSINESS WIRE)-- The Board of Trustees of Tekla Life Sciences Investors (HQL), is pleased to announce the results from the Fund’s annual shareholder meeting held today. Shareholders re-elected Oleg Pohotsky and William Reardon as Trustees of Tekla Life Sciences Investors. The shareholders also ratified the selection of Deloitte & Touche LLP as the Independent Registered Public Accountants of the Fund for its fiscal year ending September 30, 2017. In addition, the shareholders rejected a share...
CORRECTING and REPLACING Tekla Life Sciences Investors Declares Stock ...
BOSTON--(BUSINESS WIRE)-- Please replace the release dated May 19, 2017, with the following corrected version due to multiple revisions in the first paragraph. The corrected release reads: TEKLA LIFE SCIENCES INVESTORS DECLARES STOCK DISTRIBUTION On May 22, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.41 per share. The record date for the stock distribution is June 1, 2017 and the payable date is June 30, 2017. The Fund will trade ex-distribution on May 30, 2017. Th...
Tekla Life Sciences Investors Paid Distribution
BOSTON--(BUSINESS WIRE)-- On March 31, 2017, Tekla Life Sciences Investors paid a distribution of $0.36 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $133,880,093, of which $102,478,457 rep...
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Pro...
BOSTON--(BUSINESS WIRE)-- Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2017. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year-period ending July 14, 2018. The Board authorized the share repurchase program as ...
Tekla Life Sciences Investors Declares Stock Distribution
BOSTON--(BUSINESS WIRE)-- On February 17, 2017, Tekla Life Sciences Investors declared a stock distribution of $0.36 per share. The record date for the stock distribution is February 28, 2017 and the payable date is March 31, 2017. The Fund will trade ex-distribution on February 24, 2017. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23...
Tekla Life Sciences Investors Paid Distribution
BOSTON--(BUSINESS WIRE)-- On December 30, 2016, Tekla Life Sciences Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $87,360,606, of which $68,883,866 re...
Tekla Life Sciences Investors Declares Stock Distribution
BOSTON--(BUSINESS WIRE)-- On November 17, 2016, Tekla Life Sciences Investors declared a stock distribution of $0.40 per share. The record date for the stock distribution is November 28, 2016 and the payable date is December 30, 2016. The Fund will trade ex-distribution on November 23, 2016. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, Decem...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.